News on Calcineurin from BioPortfolio.com http://www.BioPortfolio.com Consolidated Calcineurin news from BioPortfolio.com Wed, 10 Feb 2010 09:00:58 GMT en Atopic Dermatitis: Researchers from Kaiser Permanente publish findings in atopic dermatitishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026242&HITNO=0&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026242&THISHREF=http://c.moreover.com/click/here.pl%3fz2530534118%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026242&HITNO=0&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026242&THISHREF=http://c.moreover.com/click/here.pl%3fz2530534118%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Partner von Isotechnika beantragt Zulassung von Voclosporin in denhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020652&HITNO=1&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020652&THISHREF=http://c.moreover.com/click/here.pl%3fz2526922501%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020652&HITNO=1&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020652&THISHREF=http://c.moreover.com/click/here.pl%3fz2526922501%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comUlitzer: Isotechnika partner files for approval of voclosporin in US and Europehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023558&HITNO=2&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023558&THISHREF=http://c.moreover.com/click/here.pl%3fz2528255784%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023558&HITNO=2&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023558&THISHREF=http://c.moreover.com/click/here.pl%3fz2528255784%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporinhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018718&HITNO=3&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018718&THISHREF=http://c.moreover.com/click/here.pl%3fz2525903316%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018718&HITNO=3&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018718&THISHREF=http://c.moreover.com/click/here.pl%3fz2525903316%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Atopic Dermatitis - Researchers from Kaiser Permanente publish findings in atopic dermatitishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010951&HITNO=4&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010951&THISHREF=http://c.moreover.com/click/here.pl%3fz2522672362%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010951&HITNO=4&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010951&THISHREF=http://c.moreover.com/click/here.pl%3fz2522672362%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Lux Biosciences seeks marketing approval in US, Europe for noninfectious uveitis treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016124&HITNO=5&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016124&THISHREF=http://c.moreover.com/click/here.pl%3fz2524647084%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016124&HITNO=5&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016124&THISHREF=http://c.moreover.com/click/here.pl%3fz2524647084%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comOSN Super Site: KMUP-1 attenuates isoprenaline-induced cardiac hypertrophy in rats through NO/cGMP/PKG and ERK1/2/calcineurin A pathwayshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002937&HITNO=6&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002937&THISHREF=http://c.moreover.com/click/here.pl%3fz2519238095%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002937&HITNO=6&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002937&THISHREF=http://c.moreover.com/click/here.pl%3fz2519238095%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBritish Journal of Pharmacology: Effect of Different Immunosuppressive Schedules on Recurrence-Free Survival After Liver Transplantation for Hepatocellular Carcinomahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3951417&HITNO=7&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3951417&THISHREF=http://c.moreover.com/click/here.pl%3fz2490197970%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3951417&HITNO=7&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3951417&THISHREF=http://c.moreover.com/click/here.pl%3fz2490197970%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTransplantation: SCY-635, a Novel Nonimmunosuppressive Analog of Cyclosporine That Exhibits Potent Inhibition of Hepatitis C Vihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952400&HITNO=8&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952400&THISHREF=http://c.moreover.com/click/here.pl%3fz2490775827%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952400&HITNO=8&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952400&THISHREF=http://c.moreover.com/click/here.pl%3fz2490775827%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAAC: The Variable Pathology of Kidney Disease After Liver Transplantationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3951415&HITNO=9&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3951415&THISHREF=http://c.moreover.com/click/here.pl%3fz2490197293%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3951415&HITNO=9&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3951415&THISHREF=http://c.moreover.com/click/here.pl%3fz2490197293%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTransplantation: Tacrolimus, a calcineurin inhibitor, overcomes treatment unresponsiveness mediated by P-glycoprotein on lymphocytes in refractory rheumatoid arthritishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3935136&HITNO=10&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3935136&THISHREF=http://c.moreover.com/click/here.pl%3fz2482508840%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3935136&HITNO=10&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3935136&THISHREF=http://c.moreover.com/click/here.pl%3fz2482508840%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Findings in medicare and medicaid reported from Armyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3911236&HITNO=11&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3911236&THISHREF=http://c.moreover.com/click/here.pl%3fz2469462308%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3911236&HITNO=11&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3911236&THISHREF=http://c.moreover.com/click/here.pl%3fz2469462308%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Intrarenal vascular resistance parameters in kidney transplant patients receiving calcineurin inhibitor-based or sirolimus-based regimenshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3885047&HITNO=12&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3885047&THISHREF=http://c.moreover.com/click/here.pl%3fz2457272778%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3885047&HITNO=12&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3885047&THISHREF=http://c.moreover.com/click/here.pl%3fz2457272778%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Brain Tumor Protein Tapped as Promising Chemotherapeutic Targethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3871616&HITNO=13&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3871616&THISHREF=http://c.moreover.com/click/here.pl%3fz2449244506%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3871616&HITNO=13&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3871616&THISHREF=http://c.moreover.com/click/here.pl%3fz2449244506%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiotech Daily: Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3863640&HITNO=14&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3863640&THISHREF=http://c.moreover.com/click/here.pl%3fz2445662314%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3863640&HITNO=14&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calcineurin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3863640&THISHREF=http://c.moreover.com/click/here.pl%3fz2445662314%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: